These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34542936)

  • 21. Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development.
    Imprachim N; Yosaatmadja Y; Newman JA
    Nucleic Acids Res; 2023 Jan; 51(1):475-487. PubMed ID: 36546776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic Platforms for Characterizing and Targeting of SARS-CoV-2 Genome Capping Enzymes.
    Ornelas MY; Thomas AY; Johnson Rosas LI; Scoville RO; Mehta AP
    ACS Synth Biol; 2022 Nov; 11(11):3759-3771. PubMed ID: 36331143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex.
    Ma Y; Wu L; Shaw N; Gao Y; Wang J; Sun Y; Lou Z; Yan L; Zhang R; Rao Z
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9436-41. PubMed ID: 26159422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants.
    Hassan SS; Bhattacharya T; Nawn D; Jha I; Basu P; Redwan EM; Lundstrom K; Barh D; Andrade BS; Tambuwala MM; Aljabali AA; Hromić-Jahjefendić A; Baetas-da-Cruz W; Serrano-Aroca Á; Uversky VN
    Comput Biol Med; 2024 Mar; 170():107899. PubMed ID: 38232455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants.
    Eckerle LD; Lu X; Sperry SM; Choi L; Denison MR
    J Virol; 2007 Nov; 81(22):12135-44. PubMed ID: 17804504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes.
    Bouvet M; Lugari A; Posthuma CC; Zevenhoven JC; Bernard S; Betzi S; Imbert I; Canard B; Guillemot JC; Lécine P; Pfefferle S; Drosten C; Snijder EJ; Decroly E; Morelli X
    J Biol Chem; 2014 Sep; 289(37):25783-96. PubMed ID: 25074927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.
    Saramago M; Bárria C; Costa VG; Souza CS; Viegas SC; Domingues S; Lousa D; Soares CM; Arraiano CM; Matos RG
    FEBS J; 2021 Sep; 288(17):5130-5147. PubMed ID: 33705595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.
    Liu C; Shi W; Becker ST; Schatz DG; Liu B; Yang Y
    Science; 2021 Sep; 373(6559):1142-1146. PubMed ID: 34315827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity.
    Case JB; Li Y; Elliott R; Lu X; Graepel KW; Sexton NR; Smith EC; Weiss SR; Denison MR
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical characterization of exoribonuclease encoded by SARS coronavirus.
    Chen P; Jiang M; Hu T; Liu Q; Chen XS; Guo D
    J Biochem Mol Biol; 2007 Sep; 40(5):649-55. PubMed ID: 17927896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response.
    Becares M; Pascual-Iglesias A; Nogales A; Sola I; Enjuanes L; Zuñiga S
    J Virol; 2016 Jun; 90(11):5399-5414. PubMed ID: 27009949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities.
    Subissi L; Posthuma CC; Collet A; Zevenhoven-Dobbe JC; Gorbalenya AE; Decroly E; Snijder EJ; Canard B; Imbert I
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):E3900-9. PubMed ID: 25197083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target.
    Tahir M
    J Med Virol; 2021 Jul; 93(7):4258-4264. PubMed ID: 33837972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA.
    Ferron F; Subissi L; Silveira De Morais AT; Le NTT; Sevajol M; Gluais L; Decroly E; Vonrhein C; Bricogne G; Canard B; Imbert I
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E162-E171. PubMed ID: 29279395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex.
    Katahira J; Ohmae T; Yasugi M; Sasaki R; Itoh Y; Kohda T; Hieda M; Yokota Hirai M; Okamoto T; Miyamoto Y
    Nucleic Acids Res; 2023 Aug; 51(14):7602-7618. PubMed ID: 37260089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent Inhibition of SARS-CoV-2 nsp14
    Ahmed-Belkacem R; Hausdorff M; Delpal A; Sutto-Ortiz P; Colmant AMG; Touret F; Ogando NS; Snijder EJ; Canard B; Coutard B; Vasseur JJ; Decroly E; Debart F
    J Med Chem; 2022 Apr; 65(8):6231-6249. PubMed ID: 35439007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
    Hsu JC; Laurent-Rolle M; Pawlak JB; Wilen CB; Cresswell P
    Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34045361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the guanine-N7 methyltransferase activity of coronavirus nsp14 on nucleotide GTP.
    Jin X; Chen Y; Sun Y; Zeng C; Wang Y; Tao J; Wu A; Yu X; Zhang Z; Tian J; Guo D
    Virus Res; 2013 Sep; 176(1-2):45-52. PubMed ID: 23702198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.
    Canal B; McClure AW; Curran JF; Wu M; Ulferts R; Weissmann F; Zeng J; Bertolin AP; Milligan JC; Basu S; Drury LS; Deegan TD; Fujisawa R; Roberts EL; Basier C; Labib K; Beale R; Howell M; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2445-2464. PubMed ID: 34198326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1.
    Zhang S; Wang J; Wang L; Aliyari S; Cheng G
    Cell Mol Immunol; 2022 Aug; 19(8):872-882. PubMed ID: 35732914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.